John L. Ziegler, MD, MSC

---

Education

Amherst College, Amherst, MA, B.A., 1956-1960, English
Cornell University Medical College, New York, NY, M.D., 1960-1964, Medicine
London School of Hygiene and Tropical Medicine, London, U.K., M.Sc., 1996-1997, Epidemiology

---

Professional Experience

• 1964-66
  Intern and Assistant Resident, Second (Cornell) Medical Division, Bellevue Hospital, New York, NY (Fellow, Department of Medicine, Cornell University Medical College)
• 1966-67
  Clinical Associate, Medicine Branch, National Cancer Institute, and Admitting Officer, National Cancer Institute
• 1967-72
  Director, Uganda Cancer Institute, Makerere University Medical School, Kampala, Uganda; Senior Investigator, Medicine Branch, National Cancer Institute
• 1972-75
  Chief, Pediatric Oncology Branch, Division of Cancer Treatment, National Cancer Institute
• 1975-80
  Deputy Clinical Director, National Cancer Institute and Associate Director, Clinical Oncology Program, Division of Cancer Treatment, National Cancer Institute
• 1980-81
  Editor-in-Chief, Journal of the National Cancer Institute, National Cancer Institute
• 1981-96
  Associate Chief of Staff for Education and Staff Physician, Veterans Affairs Medical Center, San Francisco, California; Professor of Medicine in Residence [Emeritus], School of Medicine, University of California San Francisco
• 1994-96
  Senior Scientist (on detail from Department of Veterans Affairs), International Agency for Research on Cancer, World Health Organization, Lyon, France. On special assignment to Makerere University, Kampala, Uganda. Visiting Scientist, ICRF Cancer Epidemiology Unit, Oxford University
• 1967-72
  Honorary Lecturer in Medicine, Makerere University Medical School, and Honorary Senior Registrar, Mulago Hospital, Kampala, Uganda; Lecturer in Surgery, Harvard College; Clinical Associate Professor, Cornell University Medical College
• 1976-78
  Associate Clinical Professor of Medicine, George Washington University Medical School
• 1979-81
  Associate Clinical Professor of Medicine, Georgetown University School of Medicine
• 1980-81
  Professor of Medicine, Uniformed Services University of the Health Sciences
• 1990-91
  Visiting Fulbright Professor of Medicine, Makerere University Medical School, Kampala, Uganda (on Sabbatical leave from UCSF)
• 1992-93
  Visiting Professor, University of Cambridge and Associate, Darwin College
• 1992-96
  Visiting Professor, London School of Hygiene and Tropical Medicine
• 1994-96
  Visiting Fulbright Professor of Medicine, Makerere University Medical School, Kampala, Uganda
• 1995
  Visiting Scientist, ICRF Cancer Epidemiology Unit, Oxford University
• 1996-present
  Professor in Residence Emeritus, School of Medicine, University of California San Francisco
• 1998-2008
  Director, Cancer Risk Program, UCSF Helen Diller Family Comprehensive Cancer Center

---

Honors & Awards

• July 1969
  United States Public Health Service Commendation Medal
• November 1972
  Albert and Mary Lasker Award
• November 1983
  Heath Award, M.D. Anderson Hospital
• 1990-91
  Fulbright Research Scholar, Makerere University, Kampala, Uganda
• 1991
  Howard Gilman Foundation Honors Program Lecturer, New York University
• 1992
  Associate, Darwin College, University of Cambridge
• 1994-95
  Fulbright Research Scholar, Makerere University, Kampala, Uganda
• May 2002
  Paul Carbone Memorial Award for International Oncology, Brussels
• April 2003
  Alumni Community Service Award, Hotchkiss School

---

Selected Publications

1. Baik S, Mbaziira M, Williams M, Ogwang MD, Kinyera T, Emmanuel B, Ziegler JL, Reynolds SJ, Mbulaiteye SM. A case-control study of Burkitt lymphoma in East Africa: are local health facilities an appropriate source of representative controls? Infect Agent Cancer. 2012; 7(1):5.
   View on PubMed
2. Ziegler JL. Into and out of Africa--taking over from Denis Burkitt. Br J Haematol. 2012 Mar; 156(6):766-9.
   View on PubMed
3. Powell CB, Chen LM, McLennan J, Crawford B, Zaloudek C, Rabban JT, Moore DH, Ziegler J. Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol. Int J Gynecol Cancer. 2011 Jul; 21(5):846-51.
   View on PubMed
4. Mbulaiteye SM, Talisuna AO, Ogwang MD, McKenzie FE, Ziegler JL, Parkin DM. African Burkitt's lymphoma: could collaboration with HIV-1 and malaria programmes reduce the high mortality rate? Lancet. 2010 May 8; 375(9726):1661-3.
   View on PubMed
5. Beattie MS, Crawford B, Lin F, Vittinghoff E, Ziegler J. Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers. Genet Test Mol Biomarkers. 2009 Feb; 13(1):51-6.
   View on PubMed
6. Ziegler JL, Buonaguro FM. Infectious agents and human malignancies. Front Biosci. 2009; 14:3455-64.
   View on PubMed
7. Kim DH, Crawford B, Ziegler J, Beattie MS. Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations. Fam Cancer. 2009; 8(2):153-8.
   View on PubMed
8. Carpenter LM, Newton R, Casabonne D, Ziegler J, Mbulaiteye S, Mbidde E, Wabinga H, Jaffe H, Beral V. Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda. Int J Cancer. 2008 Mar 15; 122(6):1319-23.
   View on PubMed
9. Bukhman G, Ziegler J, Parry E. Endomyocardial fibrosis: still a mystery after 60 years. PLoS Negl Trop Dis. 2008; 2(2):e97.
   View on PubMed
10. Olweny CL, Ziegler JL. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease. N Engl J Med. 2008 Feb 14; 358(7):742; author reply 743.
    View on PubMed
11. Ziegler JL. Hyper-reactive malarial splenomegaly. Am J Trop Med Hyg. 2008 Feb; 78(2):186-7.
    View on PubMed
12. Hu W, Loblay R, Ziegler J, Kemp A. Attributes and views of families with food allergic children recruited from allergy clinics and from a consumer organization. Pediatr Allergy Immunol. 2008 May; 19(3):264-9.
    View on PubMed
13. Newton R, Ziegler J, Casabonne D, Beral V, Mbidde E, Carpenter L, Maxwell Parkin D, Wabinga H, Mbulaiteye S, Jaffe H. A case-control study of cancer of the uterine cervix in Uganda. Eur J Cancer Prev. 2007 Dec; 16(6):555-8.
    View on PubMed
14. Ziegler JL, Bukhman GY. Dopamine agonists and valvular heart disease. N Engl J Med. 2007 Apr 19; 356(16):1677; author reply 1678-80.
    View on PubMed
15. Hwang ES, McLennan JL, Moore DH, Crawford BB, Esserman LJ, Ziegler JL. Ductal carcinoma in situ in BRCA mutation carriers. J Clin Oncol. 2007 Feb 20; 25(6):642-7.
    View on PubMed
16. Lubitz RJ, Komaromy M, Crawford B, Beattie M, Lee R, Luce J, Ziegler J. Development and pilot evaluation of novel genetic educational materials designed for an underserved patient population. Genet Test. 2007; 11(3):276-90.
    View on PubMed
17. Newton R, Ziegler JL, Casabonne D, Carpenter L, Gold BD, Owens M, Beral V, Mbidde E, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H. Helicobacter pylori and cancer among adults in Uganda. Infect Agent Cancer. 2006; 1:5.
    View on PubMed
18. Newton R, Ribeiro T, Alvarez E, Ziegler J, Casabonne D, Carpenter L, Beral V, Mbidde E, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Touzé A, Coursaget P. BK virus and cancer in Uganda. Eur J Cancer Prev. 2006 Aug; 15(4):285-9.
    View on PubMed
19. Fridlyand J, Snijders AM, Ylstra B, Li H, Olshen A, Segraves R, Dairkee S, Tokuyasu T, Ljung BM, Jain AN, McLennan J, Ziegler J, Chin K, Devries S, Feiler H, Gray JW, Waldman F, Pinkel D, Albertson DG. Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer. 2006; 6:96.
    View on PubMed
20. Chen Y, Toland AE, McLennan J, Fridlyand J, Crawford B, Costello JF, Ziegler JL. Lack of germ-line promoter methylation in BRCA1-negative families with familial breast cancer. Genet Test. 2006; 10(4):281-4.
    View on PubMed

View on UCSF Profiles